🟢 ChatGPT API & models 📅 Released 17 Jun 2026 Difficulty: Intermediate Agent platformsModels & training

OpenAIが自律型AI化学者による創薬反応の最適化に成功

Original title: A near-autonomous AI chemist improves a challenging reaction in medicinal chemistry

① What is it? (in three lines)

The article text below is written in Japanese.

OpenAIとMolecule.oneが共同研究を発表 GPT-5.4を活用し創薬化学の反応を改善 AIが自律的に化学実験を最適化する新手法

The headline and summary are an AI's Japanese rendering of each company's official announcement. They can diverge from the original. For the exact wording, follow the link to the official page. Terms of Use

② Main changes (3)

③ What you can now do

研究者はAIを活用して、創薬における困難な化学反応の最適化を自動化できます。これにより、新薬開発のプロセスを大幅に加速させることが可能になります。

Read the official post ↗ openai.com

🔗 Going deeper (outside articles)

Collected automatically with Gemini Search
📄 Read an excerpt of the original (152 characters)
OpenAI and Molecule.one show how a near-autonomous AI chemist using GPT-5.4 improved a key drug-making reaction, advancing medicinal chemistry research.
#OpenAI#GPT-5.4#創薬#AI化学

🔗 Related hubs and news with the same use case

🔔 Get the next one

Get plain-language summaries of new ChatGPT updates without opening the site (twice a day). No email address required.

📡 Subscribe by RSS

What is RSS: New items arrive automatically wherever you already read (a reader such as Feedly, Slack, n8n). Copy the URL above and paste it in — no sign-up, no cost.

Fetched at 18 Jun 2026, 11:35:23 · summarised at 18 Jun 2026, 11:36:29